The relationship between hsCRP (high-sensitivity C-reactive protein) and fatigue is indirect, mediated by chronic low-grade inflammation. hsCRP is a well-established biomarker for systemic inflammation. Observational studies consistently link elevated hsCRP levels with fatigue in conditions such as chronic fatigue syndrome, fibromyalgia, depression, and autoimmune diseases. The proposed mechanism involves pro-inflammatory cytokines (e.g., IL-6, TNF-α) stimulating hepatic hsCRP production while also acting on the brain to induce 'sickness behavior' and fatigue via neuroinflammation and neurotransmitter modulation. However, the evidence is largely correlational; causal proof is lacking. Randomized controlled trials that reduce hsCRP (e.g., with statins or lifestyle changes) and measure fatigue show mixed results. Fatigue is multifactorial—influenced by sleep, stress, diet, and physical activity. A single hsCRP measurement should not be used alone to diagnose or explain fatigue. For MyBody-X users: hsCRP can be a useful component of an inflammatory panel, but interpretation requires clinical context. The evidence for a direct causal link between hsCRP and fatigue is moderate at best, based on observational human studies.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-500c48b549591e5a01c08efd